H.R.4712 To amend the Federal Food, Drug, and Cosmetic Act with respect to limitations on exclusive approval or licensure of orphan drugs, and for other purposes.
Sponsored by Madeleine Dean (D). Introduced on 2019-10-17 in the House Energy and Commerce Committee. The last major action was Referred to the House Committee on Energy and Commerce which took place on 2019-10-17.
The full legislation document not yet available.
This legislation was co-sponsored by Marc Veasey (D), Buddy Carter (R), and David McKinley (R).
10/17/2019 - Referred to the House Committee on Energy and Commerce.